Qatar‘s health authorities have ordered the withdrawal of all batches of Isotears-Plus eye drops from the market following concerns identified during inspections of the manufacturing facility. Consumers who have purchased the product have been advised to stop using it immediately as a precautionary measure.
The recall follows observations involving data integrity and sterile processing procedures at the production site. Isotears-Plus is a lubricating solution commonly used to relieve temporary burning, irritation and discomfort associated with dry eyes and environmental exposure.
Click here to join our WhatsApp channel here
The announcement comes just days after a separate recall involving all batches of Clasgen 0.05% eye drops, which was also linked to concerns over data integrity and sterile manufacturing processes. Clasgen is a prescription treatment used to manage chronic dry eye disease by reducing inflammation on the eye’s surface and supporting natural tear production.
Authorities have not confirmed whether the two recalls are connected. The decisions highlight the importance of maintaining strict pharmaceutical manufacturing standards, product quality controls and regulatory monitoring to safeguard patients.
Also read: Aster Guardians Global Nursing Award 2027 Opens Nominations with USD 250,000 Prize
